HR3731Referred to Committee

Small Biotech Innovation Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-06-04
Introduced
3
Cosponsors
HR
Type

Sponsor

August Pfluger
August Pfluger
Republican · TX · Representative
Votes with party: 98.9% (545 recorded votes)

Full profile: /officials/P000048

Source: Congress.gov · FEC

Cosponsors (3)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-06-04

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill aims to support smaller biotechnology companies by likely providing tax breaks, regulatory relief, or funding to help them develop new medicines and treatments more easily. The changes would reduce some of the financial and bureaucratic barriers that small biotech firms face compared to large pharmaceutical companies, potentially speeding up innovation in areas like rare diseases or personalized medicine. The bill is currently being reviewed by two congressional committees to determine which parts fall under their respective responsibilities.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.

Related legislation

Bills by the same sponsor or covering overlapping subjects.